Alzheimer's Disease Trial, Recruiting NCT03851523 Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT03851523
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women who are between 45 and 74 years old and previously took part in a study called "45-65/FPM2012," or anyone over 45 years old who did not take part in that earlier study.
  • People who are either experiencing normal memory concerns, have mild memory or thinking difficulties (mild cognitive impairment), or have been diagnosed with mild dementia.
  • A family member or close relative must be available and willing to take part in an interview about the participant's memory concerns.

Who may not be able to join:

  • People with a serious or unstable physical health condition that could make it difficult to follow the trial's procedures.
  • People who have a significant condition that affects memory or thinking for reasons unrelated to Alzheimer's disease.
  • People who have a strong family history of a rare, inherited (genetic) form of Alzheimer's disease that is directly passed down through families.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Registry
ClinicalTrials.gov
Start date
12 February 2018
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Subjective Cognitive Decline Questionnaire (my-Cog); Subjective Cognitive Decline Questionnaire (their-Cog)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov